Company / R&D Expense
Lifevantage Corp R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$700.0K
FY2025
5-year range
$600.0K / $1.1M
FY2021-FY2025
Trend
+16.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense returned to growth in FY2025 after 4 years of decline, reaching $700,000.
Based on SEC 10-K filings.
$700,000 in FY2025 with a 5-year CAGR of -10.2%.
Remained stable around $700,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -8.0%
- 5-Year CAGR
- -10.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -10.2%, indicating a declining trend.
- In FY2025, r&d expense increased 16.7% year-over-year.
- Peak r&d expense was recorded in FY2017.
- Lowest r&d expense in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $700.0K | +16.7% |
| FY2024 | $600.0K | -14.3% |
| FY2023 | $700.0K | -22.2% |
| FY2022 | $900.0K | -18.2% |
| FY2021 | $1.1M | -8.3% |
| FY2020 | $1.2M | +9.1% |
| FY2019 | $1.1M | +10.0% |
| FY2018 | $1.0M | -58.3% |
| FY2017 | $2.4M | +20.0% |
| FY2016 | $2.0M | -31.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026